Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 15;401(10384):1302-1312.
doi: 10.1016/S0140-6736(23)00001-6. Epub 2023 Mar 14.

Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact

Collaborators, Affiliations

Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact

Edward W Gregg et al. Lancet. .

Abstract

The Global Diabetes Compact is a WHO-driven initiative uniting stakeholders around goals of reducing diabetes risk and ensuring that people with diabetes have equitable access to comprehensive, affordable care and prevention. In this report we describe the development and scientific basis for key health metrics, coverage, and treatment targets accompanying the Compact. We considered metrics across four domains: factors at a structural, system, or policy level; processes of care; behaviours and biomarkers such as glycated haemoglobin (HbA1c); and health events and outcomes; and three risk tiers (diagnosed diabetes, high risk, or whole population), and reviewed and prioritised them according to their health importance, modifiability, data availability, and global inequality. We reviewed the global distribution of each metric to set targets for future attainment. This process led to five core national metrics and target levels for UN member states: (1) of all people with diabetes, at least 80% have been clinically diagnosed; and, for people with diagnosed diabetes, (2) 80% have HbA1c concentrations below 8·0% (63·9 mmol/mol); (3) 80% have blood pressure lower than 140/90 mm Hg; (4) at least 60% of people 40 years or older are receiving therapy with statins; and (5) each person with type 1 diabetes has continuous access to insulin, blood glucose meters, and test strips. We also propose several complementary metrics that currently have limited global coverage, but warrant scale-up in population-based surveillance systems. These include estimation of cause-specific mortality, and incidence of end-stage kidney disease, lower-extremity amputations, and incidence of diabetes. Primary prevention of diabetes and integrated care to prevent long-term complications remain important areas for the development of new metrics and targets. These metrics and targets are intended to drive multisectoral action applied to individuals, health systems, policies, and national health-care access to achieve the goals of the Global Diabetes Compact. Although ambitious, their achievement can result in broad health benefits for people with diabetes.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests WHO provided financial support and two affiliated advisers contributed as authors. EWG and JB report receiving consultation funding from WHO related to this work. EWG also receives funding from UK Royal Society and Science Foundation Ireland. Authors report the following funding unrelated to this study and report: MKA reports funding from Merck, Bayer, and Eli Lilly; RM reports consulting fees from Novo Nordisk, Eli Lilly, Boeheringer Ingelheim, Sanofi, and AstraZeneca; L-LL reports grants or honoraria from AstraZeneca, Boeheringer Ingelheim, Abbott, Merck Sharp & Dohme, Sanofi, Servier, Zuellig Pharma, and Pfizer; JPS reports funding from Novo Nordisk and Pfizer; JES reports funding from AstraZeneca, Sanofi, Novo Nordisk, MSD, Eli Lilly, and Pfizer, Mylan, Sanofi, Boehringer Ingelheim, and Zuellig Pharma. All other authors declare no competing interests.

Figures

Figure 1.
Figure 1.
Methods and steps to recommend Global Diabetes Compact metrics and targets.
Figure 2.
Figure 2.. Proposed core, complementary, and base metrics for the Global Diabetes Compact.
Recommended core metrics shown in black, complementary metrics in blue, and base metrics in green. The core metrics are intended for priority implementation by UN member states and monitoring by the Global Diabetes Compact. The complementary metrics currently lack adequate global data availability or consensus-based definitions but should be considered for scale-up in population health data and surveillance systems. Base metrics are additional processes or health indicators that are essential for the calculation of core and complementary metrics.

Comment in

Similar articles

Cited by

References

    1. Federation ID. IDF Diabetes Atlas. 2021. www.diabetesatlas.org.
    1. Chan JCN, Lim LL, Wareham NJ, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet 2021; 396(10267): 2019–82. - PubMed
    1. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016. - PMC - PubMed
    1. Williams R, Karuranga S, Malanda B, et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2020; 162: 108072. - PubMed
    1. Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 2017; 5(6): 423–30. - PubMed

MeSH terms

Substances